Acute renal failure in the newborn.

Area of Science:

• Neonatology
• Pediatric Nephrology
• Critical Care Medicine

Background:

• Acute renal failure (ARF) in newborns is a significant clinical problem with diverse etiologies.
• Causes include congenital anomalies, hypoxic-ischemic injury, and nephrotoxic exposures (e.g., aminoglycosides, NSAIDs).
• ARF is frequently observed in neonatal intensive care units, with potential genetic predispositions.

Purpose of the Study:

• To review the classification, causes, and management of acute renal failure in newborns.
• To highlight the diagnostic and therapeutic challenges in this vulnerable population.
• To discuss the prognostic factors and long-term implications of neonatal ARF.

Main Methods:

• Review of existing literature on neonatal acute renal failure.
• Classification of ARF into prerenal, intrinsic renal disease, and obstructive uropathy.
• Discussion of diagnostic approaches and management strategies, including renal replacement therapy.

Main Results:

• ARF in newborns can be congenital or acquired, with hypoxic-ischemic insults and nephrotoxins being common postnatal causes.
• Renal replacement therapies include peritoneal dialysis, hemodialysis, and hemofiltration, with increasing preference for hemofiltration.
• Prognosis is strongly tied to the etiology, with factors like multi-organ failure and hemodynamic instability associated with higher mortality.

Conclusions:

• Neonatal ARF requires comprehensive management of metabolic derangements and appropriate renal support.
• Long-term monitoring for hypertension and chronic kidney disease is crucial, especially after significant nephron loss.
• Understanding the underlying etiology is paramount for determining prognosis and guiding treatment in newborns with ARF.